Drug design - Chemistry and biology

[1] AHAGYAN R, 2001, CURR OPIN CHEM BIOL, V5, P375

[2] Antel J, 1999, Curr Opin Drug Discov Devel, V2, P224

[3] BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) : 3482 - 3486

[4] Beeley L J, 2000, Prog Med Chem, V37, P1, DOI 10.1016/S0079-6468(08)70056-0

[5] Bohacek R, 1999, IMA V MATH, V108, P103

[6] Modern computational chemistry and drug discovery: structure generating programs [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) : 157 - 161

[7] Structure-based library design:: molecular modelling merges with combinatorial chemistry [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2000, 4 (03) : 283 - 286

[8] Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (11) : 2135 - 2148

[9] Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (13) : 2080 - 2093

[10] Chemogenomic approaches to drug discovery - Commentary [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) : 464 - 470

[1] AHAGYAN R, 2001, CURR OPIN CHEM BIOL, V5, P375

[2] Antel J, 1999, Curr Opin Drug Discov Devel, V2, P224

[3] BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) : 3482 - 3486

[4] Beeley L J, 2000, Prog Med Chem, V37, P1, DOI 10.1016/S0079-6468(08)70056-0

[5] Bohacek R, 1999, IMA V MATH, V108, P103

[6] Modern computational chemistry and drug discovery: structure generating programs [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) : 157 - 161

[7] Structure-based library design:: molecular modelling merges with combinatorial chemistry [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2000, 4 (03) : 283 - 286

[8] Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (11) : 2135 - 2148

[9] Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (13) : 2080 - 2093

[10] Chemogenomic approaches to drug discovery - Commentary [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) : 464 - 470